drugset / Trial / NCT03872336
Acute Labetalol Use in Preeclampsia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to understand if administration of a personalized dose of the anti-hypertensive medication, labetalol, based on patient's body-mass index, will be more effective at controlling severe hypertension during pregnancy, compared to the current standard dosing.
Timeline
- Start
- 2019-02-18
- Primary completion
- 2020-07-20
- Completion
- 2020-07-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Labetalol | Small molecule | 80 mg | Intravenous |